BrainsWay recently received de novo clearance from the U.S. Food and Drug Administration (FDA) for its deep transcranial magnetic stimulation (Deep TMS) system for treating obsessive compulsive disorder (OCD) in adults.

Technology has streamlined many aspects of healthcare, but outcomes are further improved when doctors actually follow alerts prompted by electronic health records (EHRs), according to a recent study.

As the debate around rising drug prices heightens, pharmacy benefit managers are taking on more scrutiny over copays that are sometimes higher than buying the drug out of pocket.

Most Americans are OK with the genetic engineering of animals if it benefits human health, according to a survey conducted by the Pew Research Center.

Google is reportedly developing a wellness app that will be powered by artificial intelligence (AI), according to a report by Venture Beat.

CMS has announced moves to make it easier to implement changes to the Medicaid program more quickly, the agency announced Thursday.

Patients of physicians who use computerized alerts are less likely to suffer complications. The systems can also lower readmission rates, lengths of stay and costs, according to a study in the American Journal of Managed Care.

Considering the pervasiveness of opioid misuse and abuse, people find novel avenues to access the drugs. FDA Commissioner Scott Gottlieb, MD, released a statement outlining resource guide for veterinarians to prescribe opioids for animals.